SCIENTIFIC ADVISORY BOARD (SAB) OF J. MICHAEL BISHOP INSTITUTE OF CANCER RESEARCH HELD ITS FIRST MEETING IN CHENGDU

Chengdu, China, October 8-15, 2018?– The first meeting of the Scientific Advisory Board (SAB) of the J. Michael Bishop Institute of Cancer Research (MBICR) was?held between?October 8 and 15, 2018 in Chengdu, China. The board was?led?by Dr. J. Michael Bishop (the chairman of the SAB) who presided over the meeting.?The SAB comprises five of the world’s leading experts in research areas which are?of?great interest to the MBICR.?

?

These are the members of the Scientific Advisory Board of the J. Michael Bishop Institute of Cancer Research:

  • ? ? ? ??Dr. J. Michael Bishop, Nobel Laureate and Chancellor Emeritus of UCSF
  • ? ? ? ??Dr. Robert Lloyd FRS, Professor of Genetics, University of Nottingham
  • ? ? ? ??Dr. James Naismith FRS, Professor of Structural Biology, University of Oxford
  • ? ? ? ??Dr. Scott Kogan, Professor of Pathology, UCSF
  • ? ? ? ??Dr. Kevan Shokat, Professor of Pharmacology, UCSF and UC/Berkeley

?

The purpose of the annual meeting was to review the MBICR’s scientific and administrative strategies. Furthermore, the SAB meeting was also held?to?advise the Institute on the administrative issues, on the innovative development of the Institute’s research and development activities, and lastly, on the hot topics for promising projects with possible high impact in the future.

?

During the meeting week, SAB members took time to?tour?the MBICR headquarters in the making which is located in the Tianfu International Bio-town, Gaoxin District, Chengdu. The 3-D rendering of the interior design of this building was presented to the SAB members for their views and comments. They also visited the Keiyuan campus of MBICR, where they inspected the laboratories for equipment, technologies, and infrastructures;?chatted with MBICR employees about their working environment and career development plans;?and attended a poster presentation session of research progress report.?

?

At the Chengdu University of Traditional Chinese Medicine, Dr. Dun Yang, Director of MBICR, delivered a Status Report at the public session of the 2018 SAB Meeting. In?the?Status Report presented, Dr. Yang?described?the history, aims, visions, and strategic planning of the institute;?reviewed?scientific research projects completed, ongoing, and planned since the inauguration of the Institute two years ago; and?gave?an account of the Institute’s budget, the sources, and deployment of funds. He also?presented?overviews of the institute’s structure and organization, institute’s core facilities, personal structure, information on the career development, and information on cooperation with other research institutions and universities.?

?

Immediately?after?the speech?has been?delivered,?the Institute’s Board of Directors held a private meeting with SAB members to address various questions raised by the SAB members. After the scientific sessions, the SAB conducted its closed session to prepare the final report. To conclude the 2018 SAB meeting, Dr. J. Michael Bishop orally presented to the Institute’s Board of Directors the collective views that the SAB members have reached. The oral report was complemented by a written summary by the SAB board member Dr. Robert Lloyd FRS.

?

In general, the board?was?highly impressed and satisfied with the progress that the institute has accomplished within two years. In particular, they endorsed and provided valuable suggestions to the institute’s efforts in constructing natural products libraries for high-throughput drug screening and developing synthetic lethal therapeutics from natural products for the treatment of cancer. All SAB members expressed their enthusiasm about the future of the institute and signified their willingness to help in any respect that the institute might need them.?At?the end of the?meeting,?the SAB raised several critical issues that need to be taken care of by the Institute Board of Directors before the next SAB Meeting.?

?

The bottom line is that?this is a very successful inaugurating SAB Meeting with intense and stimulating discussions, critical questions, and important inputs,” said Dr. Jing Zhang, Co-director of MBICR. “We are very grateful for the thoughtful feedback and advice.?We would also like to thank our institute researchers and administrative staff who did a great job to represent our institute.?Everyone had a happy experience and is looking forward to the next SAB Meeting in 2019.”, She concluded.

?